research: selective reduction of inflammation to halt cancer growth
Posted Dec 20 2010 12:00am
This research indicates that inflammation in breast tissue, spurred by the activity of the NFKB* pathway, causes cancer. If this inflammation can be isolated from the inflammation in the rest of the body and selectively treated, it could mean that … Continue reading →
This research indicates that inflammation in breast tissue, spurred by the activity of the NFKB* pathway, causes cancer. If this inflammation can be isolated from the inflammation in the rest of the body and selectively treated, it could mean that … Continue reading →